Full Article at IIR has reaffirmed its Recommended rating for PIA after undertaking a review post the appointment of a new Portfolio Manager, Harding Loevner. The full report can be found on the IIR website. On 26 July 2021, Pengana International Equities Limited (PIA) announced a fully franked dividend of 1.35 cents per share for the June quarter. This represents an 8% increase on the March quarter dividend and takes the total dividends declared for FY21 of 5.1 cents per share, fully franked....
Everest Medicines is a China-based biotech company with late-stage drug candidates in-licensed from partner pharmaceutical companies and biotechs. In our previous note, we discussed that the company has experienced biotech investor managers as its top management. Its business model is to in-license drug candidates with unmet demand in China. We highlight the most interesting drug candidates is TROP-2 targeted Trodelvy which has a broad indication given the prevalent presence of this target in...
Everest Medicines is a China-based biotech company with late-stage drug candidates in-licensed from partner pharmaceutical companies and biotechs. The company has experienced biotech investor managers as its top management. Its business model is to in-license drug candidates with unmet demand in China. We highlight the most interesting drug candidates is TROP-2 targeted Trodelvy which has a broad indication given the prevalent presence of this target in tumor cells. Its innovative antibioti...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.